Petplan has revealed the top 10 most claimed for health conditions in cats and dogs for 2011.
They were:
VetSurgeon.org member Aubrey Kumm MRCVS, a Joint Partner at Companion Care in Harlow, has become one of the first vets based in the UK to gain the GPCert(Endo) from the ESVPS. He joins a group of just 11 vets who currently hold this certificate in Europe.
Aubrey said: "Although there are over 50 veterinary surgeries offering specialist endoscopic surgery in the UK I wanted to ensure I was as well versed as possible in the latest developments of this method of surgery and the ESVPS certificate offered a comprehensive course, the benefits of which I am now able to pass on to clients."
Aubrey's qualification involved a year of study and several examinable components including case studies and a written exam.
The practice has invested around £60,000 in a Force Triad and two laprascopic cameras, along with various operating scopes, a broncoscope,and other associated equipment.
Aubrey added: "As a practice we are now able to offer less invasive surgery to our clients and their pets and we no longer have to ask clients to travel to distant referral centres."
Husky, a rather aptly named refrigeration company, has announced it is to launch a veterinary vaccine fridge.
According to the company, the new fridge is a specially adapted version of its SS1 model, one of the most popular refridgerators for caterers because of its performance, reliability and durability.
The new unit is designed to ensure the safe storage of a wide range of vaccines at 2º - 8º degrees Celsius. The unit also incorporates an audible door open alarm, failed temperature alarm, and a fail-safe secondary back-up digital display thermometer as an added safeguard.The vaccine refrigerator door includes security lock as standard, and the refrigerant used in manufacture is R600, a highly efficient hydrocarbon refrigerant coolant - CFC-free and a natural non-greenhouse gas.
Geoff Thomasson, Chief Executive of the Husky team of companies said: "The SS1 has long been a winner with the hospitality trade and we believe we will enjoy similar success with this medical version. The potential market is enormous."
For more information, ring 01455 555340 or email: info@husky-global.com
Kruuse has announced that it has become the exclusive distributor for VideoMed GmbH and its range of veterinary endoscopes and documentation systems.
VideoMed produces a range of equine and small animal endoscopes, gastroscopes and laryngoscopes that multifunction with a flexible documentation console. This provides a mobile capability to file, frame and forward digital and dicom images for review and referral diagnosis.
According to Kruuse, VideoMed products are synonymous with the very highest quality of design, function and reliability that have been developed through years of close working relationship with veterinary professionals. An after care and repair service is also provided by the company for its own and a range of other scopes.
Kruuse says the Overground scope gives a mobile, high resolution, recordable image that clearly determines functional and morphological abnormalities of the larynx, pharynx and upper respiratory system (see image right).
Andrew Groom, Managing Director, Kruuse UK Ltd., said: "This exciting agreement will further enhance our equine and small animal presence within the veterinary industry to bring even more leading edge technology to our customers."
For more information, visit www.kruuse.com and http://www.videomed-gmbh.de/
Picture courtesy of:Neil Townsend MSc BVSc Cert ES (Soft Tissue) DipECVS MRCVSClinician in Equine Soft Tissue SurgeryPhilip Leverhulme Equine Hospital
Pfizer's Vet Support+ has launched the Practice Management Academy, which offers online training in the key management disciplines required to run a successful veterinary business.
There are twelve courses which cover four key areas of management: financial operations, staff management, client relations and marketing. Participants can choose to study individual courses, a specific area of management, or enrol in the full Practice Management Academy.
The courses are four weeks in length and contribute up to ten hours of CPD learning through a mix of interactive activities, case studies, questions and a student learning forum.
Each course is also allocated a Pfizer Business Consultant to work as an online expert tutor, posing questions and stimulating forum discussion amongst the students.
Pfizer says that the significant cost saving e-learning represents over external CPD is making the Academy a popular choice for all members of the practice team, especially those who may be taking on new management responsibilities or those looking for a refresher. According to the company, one large vet group has already taken twenty places on each of the courses to improve the practice management skills across its extensive team.
Ned Flaxman, Director Business Innovation said: "Using an E-Learning platform is a well-trodden path, ideal for busy individuals wishing to improve or gain new practice management skills without leaving the surgery, or sofa. However, unlike some e-learning which can leave the participant feeling like they are gaining theoretical know-how only, and working in somewhat of a silo, our Academy offers an 'online campus'. This provides a flexible, convenient and supportive training environment for shared theory and practical learning with other colleagues from the veterinary profession under the guidance of e-tutors and experts."
For further details visit http://www.vetsupportplus.co.uk/
Vets Now has won the 'Social Entrepreneur of the Year' award in the Scottish Business Awards for Pet Blood Bank UK.
The charity was initiated by a Vets Now employee, Wendy Barnett, following a change in legislation which created the opportunity to establish a pet equivalent of the human national blood transfusion service. After a trial through Vets Now, Pet Blood Bank UK was set up in 2007 as an independent charity, with a loan and ongoing fundraising support from Vets Now.
Pet Blood Bank UK collects blood from donor dogs, processes it and supplies it to the veterinary profession to use in cases such as traumatic injuries or where major surgery is required. Last year 164 specially organised dog donor sessions were held where owners are encouraged to bring along their dog to 'donate a pint'. Each donation has the potential to save up to four lives. Nearly 9,000 units of blood have been collected in the past five years.
The charity, which has an education and animal welfare remit, charges veterinary practices just the costs incurred in collecting, processing and storing the blood. As well as providing blood, the Pet Blood Bank UK team are experts in transfusion medicine and receive numerous calls through their advice service. Regular lectures, educational talks to the profession and guidance is given to enquiries from all over the world on how to set up a blood bank.
Wendy Barnett, who is now Head of Clinical and Professional Services at Pet Blood Bank UK, said: "At the heart of our charity is a real desire to ensure that should a dog need blood there is a supply available and I'm delighted that our work, and the support of our many doggy donors and their owners, has been recognised through this award.
"Literally thousands of dog lives have been saved as a result of the service and this has been a real collective effort with Vet Supervisor Jenny Walton and the team here contributing to our success. However, we can't rest on our laurels. Demand from vets has been such that we've had to increase our donor sessions considerably. Like humans, there is a less common dog blood type and we desperately need dogs with negative blood type - such as Greyhounds, Weimaraners, Flat Coat Retrievers, Airedales, Boxers, Dobermans and German Shepherd Dogs to donate at our sessions."
Richard Dixon, founder of Vets Now, said: "Wendy was instrumental in setting up the charity and through her vision and leadership donation sessions have grown from one to three a week, with a 38% increase in donations year on year. We are proud of what Wendy has achieved and the role that the charity now plays in providing much needed blood and guidance to veterinary practices the length and breadth of the UK."
The RCVS Disciplinary Committee has dismissed a case against an Essex-based veterinary surgeon, having found him not guilty of charges relating to the measurement of horses and ponies.
At the ten-day hearing, Marc Auerbach of Oak Equine Veterinary Surgery, Ongar, answered charges relating to measuring the height of 29 horses/ponies presented for measurement by two agents in early 2009. Dr Auerbach had undertaken these measurements as an Official Measurer (OM) for the Joint Measuring Board (JMB), which provides a system for independently measuring and certifying the size of competition horses/ponies. An animal's financial value relates to its size, with larger animals being more likely to win in their competitive class.
The case centred on the expected accuracy of such measurements, whether Dr Auerbach was dishonest in colluding with the agents, or whether there had been signs of malpractice which a reasonably competent vet acting as an OM ought to detect.
From evidence submitted, the Committee determined a margin for measurement accuracy, and consequently dismissed from its consideration ten animals where the difference between the initial measurement and the re-measurement was 3 cm or less. However, the College submitted that the average difference was so great that, either, Dr Auerbach had failed to take sufficient steps to ensure that the correct measurements were recorded, or else he had been dishonest. Dr Auerbach's Counsel accepted the inference that presenting agents were dishonest, but denied that Dr Auerbach was dishonest or had failed to pick up signs of malpractice on the part of the agents.
The Committee was of the view that there may be unscrupulous presenters capable of materially interfering with the height of horses. While it was unable to determine with certainty the extent to which it could be done, the Committee formed the view that unscrupulous interference (together with intrinsic variables) could have caused the differences between measurement and re-measurement in the 19 horses.
The Committee noted there was no evidence of improper payments being received by anyone. It also accepted evidence that Dr Auerbach was not a dishonest man, taking into account his record of 23 years of honesty and excellence in the profession, unchallenged character references and the lack of any credible motive for him to act dishonestly.
Next, the Committee considered whether there had been signs of preparation malpractice which ought to have been picked up by any reasonably competent veterinary surgeon acting as an OM. The College submitted that Dr Auerbach had failed to take several steps including the amount of time and attention given to the animals he measured, and whether they might be drugged or sedated.
The Committee concluded from the evidence, including scientific papers, that mildly sedated animals may not be distinguishable from properly prepared animals; well-behaved horses were not an indication that something was amiss. The Committee accepted that Dr Auerbach took around 15-20 minutes to measure each of the horses presented on 9 January; and, in the absence of guidance from the JMB, it could not conclude this was rushed or unreasonable. Consequently, the Committee was unable to be satisfied, so that it was sure, that the allegation of failure to take sufficient steps to ensure the recording of correct measurements was proved.
"Accordingly, the decision of the Committee is that the facts set out in the Charge in relation to all the horses and ponies listed have not been proved to the necessary standard of proof," said Prof Peter Lees, speaking on behalf of the Committee as he directed the charges be dismissed.
Boehringer Ingelheim Vetmedica has launched Benefortin (benazepril hydrochloride), an ACE inhibitor licensed for the treatment of congestive heart failure (CHF) in dogs. It is also licensed for the treatment of chronic renal insufficiency (CRI) in cats.
Benefortin uses novel micro-cap technology to mask the taste of the bitter molecule. According to Boehringer, this ensures that Benefortin tastes good1, even if it is bitten, crunched or chewed. The company says taste tests demonstrated 100% palatability in dogs and 92% palatability in cats in home settings1.
Benefortin is available in 5mg and 20mg tablets for dogs and 2.5mg tablets for cats and dogs.
Jemima Scott, Boehringer Ingelheim brand manager said: "The addition of Benefortin to our cardiology portfolio now enables us to provide veterinary practices with two of the cornerstones of canine CHF treatment, and the palatability of Benefortin makes it an excellent choice for vets needing to prescribe an ACE inhibitor."
To support the launch of Benefortin, Boehringer is offering veterinary practices the opportunity to win one of three Bosch microwave ovens in a prize draw by answering three multiple choice questions on the ACE inhibitor.
For further information on Benefortin, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
A new study has revealed that owners of obese dogs which successfully lose weight notice significant improvement in their dogs' quality of life too.
The study, published in The Veterinary Journal and available online here, was conducted by scientists from the Royal Canin Weight Management Clinic at Liverpool University in conjunction with the Pain and Welfare Group at the University of Glasgow and the Waltham Centre for Pet Nutrition. It looked at fifty obese dogs that had been referred to Royal Canin's clinic.
The results showed that quality of life improved in the dogs that successfully lost weight, demonstrated by increased vitality scores and decreased scores for emotional disturbance and pain. The improvements in vitality score were greater the more body fat the dogs lost. The research also found that the dogs that failed to complete their weight loss programme had lower vitality and higher emotional disturbance scores than those successfully losing weight.
Dr. Alex German, Royal Canin senior lecturer at the University of Liverpool and lead author of the study, said: "Obesity is a risk for many dogs, affecting not only their health, but also their quality of life. The results indicate that, for obese dogs, weight loss can be important for staying both healthy and happy."
Owners completed a questionnaire to determine the health-related quality of life of their dog prior to weight loss, with a follow-up questionnaire for the owners of the thirty dogs that successfully completed the weight loss programme to reach target weight. The completed questionnaire responses were converted into scores corresponding to a range of factors, including vitality, emotional disturbance and pain.
The BSAVA has released a statement in support of the television programme Pedigree Dogs Exposed - three years on, made by Jemima Harrison. The programme was broadcast earlier this week on BBC4 as a follow up to a documentary which was first shown in 2008.
BSAVA President Andrew Ash said: "Jemima Harrison has highlighted an important issue. It is essential that veterinary surgeons, dog breeders and the general public no longer accept that breeding for extremes of conformation or knowingly from animals with inherited disease is an acceptable practice. The programme highlighted two main areas of concern, firstly the small genetic pool that exists in many breeds and secondly continued breeding for extremes of body shape. Both these areas must be addressed urgently. A civilised nation must agree that it is not acceptable to breed dogs that cannot function as dogs."
He went on to say that: "BSAVA supports the health schemes that are now available to owners as steps in the right direction. However it is difficult to believe that health schemes are going to be sufficient in themselves to tackle these problems rapidly and effectively. It is particularly perverse to be promoting health schemes and yet continuing to allow the registration and showing of progeny with Coefficients of Inbreeding as high as 47.5% or where the animal concerned is known to have failed a screening test (significant in that breed)."
Vice President Mark Johnson said: "We are supportive of the changes that the Kennel Club has made so far, and applaud them in allowing the introduction of new genes into certain breeds as demonstrated by the registration of the LUA Dalmatian. I support the introduction of the "Mate Select" scheme (link) but believe that the Kennel Club should adopt the Advisory Council on Welfare in Dog Breeding recommendation and not register puppies with a coefficient of breeding (over 5 generations) greater than 12.5%."
The BSAVA says it supports the BVA in its call for a radical review of all breed standards to ensure that they actively protect the health and welfare of the dog. However it is important to remember that inherited disease is not just a problem of purebred dogs and BSAVA supports the introduction of legislation that seeks to improve the health and welfare of all dogs.
Boehringer Ingelheim is offering a free stainless steel bolus applicators, worth £42.60/€ 59.39 (plus VAT), with the first 1,000 Bovikalc multipacks sold after 1st March in the UK and Eire.
According to the company, milk fever is recognised as the most common mineral deficiency affecting transition cows; one that has a significant impact on the overall health of affected animals, even those showing no outward symptoms. This offer aims to help combat this costly but preventable disease.
The offer is open to farmers, vets and suppliers of Bovikalc and one free applicator will be provided for each Bovikalc multipack - 6 x 4 boluses.
Farmers are required to apply for the free applicators through their veterinary surgeon or Bovikalc supplier.
For further information, including the terms and conditions of the offer, visit www.bovikalc.co.uk. Alternatively, contact your regional cattle specialist or call Boehringer on 01344 746959.
Over 100 students from Nottingham Vet Society will attempt the 3 Peaks Challenge by climbing Ben Nevis, Scafell Pike and Snowdon in under 24 hours on 10 March.
The funds raised will be split between VBF, the charity that supports veterinary professionals, and Medical Detection Dogs.
Online donations can be made at http://goo.gl/IkodW.
Lydia Brown, VBF President, said: "We are so grateful to the students involved who organized this off their own backs even though they don't have much free time. It augurs well for the future of the profession that they want to support their colleagues. I do hope they all make it back to Nottingham safely and I look forward to seeing the pictures on facebook.com/VetlifeVBF! "
Tom McKay, one of the students who organized the challenge, said: "We have really enjoyed the training and are reasonably optimistic we will make it back for our Easter placements!"
Companion Care Vets has been named as one of The Sunday Times 100 Best Companies To Work For, the first veterinary organisation to receive the accolade.
Companion Care, which has 90 surgeries across the UK (the majority within Pets at Home stores) launched its joint venture partner model in 2001. The group received a "first class" one-star status from The Sunday Times, and was ranked at number 69 overall, a position determined by employee views, staff policies, processes and services.
Best Companies Accreditation is based around employee engagement and listed companies are noted for "excelling in every area throughout the workplace." Particularly recognised is an organisation's commitment to its most important assets - its workforce.
Jane Balmain, Managing Director of Companion Care Vets said: "We value every member of our team who have all worked tirelessly over the past 11 years to help our expansion into the market leader we are today. Without the commitment and expertise of every person within the organisation this would not have been possible and for us to receive this recognition, and on our first try, is outstanding."
Jane added: "To be the first veterinary organisation to receive Best Companies Accreditation is an honour and we will strive to continue to provide an exceptional working environment for our teams."
As part of the survey process 79% of Companion Care Vets' employees said their jobs are good for personal growth, 76% felt their jobs were secure and a fantastic 81% said colleagues are committed to taking care of each other.
With 109 Joint Veterinary Partners and a further 867 employees in the group, Companion Care Vets is one of the largest veterinary employers in the UK. The company plans to have 200 surgeries in place by 2015 which will create a host of career opportunities for vets and veterinary support teams around the UK.
Novartis Animal Health has announced that it is offering regular updates Schmallenberg virus, including the number and counties of affected farms, on its farm animal health website: www.farmanimalhealth.co.uk.
The new website is a resource for vets, SQPs and farmers and also contains background information on the virus, its symptoms and suggestions for control.
Helen Langham, Brand Manager at Novartis Animal Health, said: "There is still a lot that isn't known about the Schmallenberg virus, so it is essential that those involved in the animal health industry and livestock production are kept informed. Our website provides current information and links to relevant resources to help people stay up to date".
For more information go to www.farmanimalhealth.co.uk/latestdiseaseupdates
The candidates for this year's RCVS Council election have been announced, many of whom will be coming to the VetSurgeon.org forums to lay out their stalls and explain why you should vote for them.
A record number of veterinary surgeons - 14 - are contesting six seats in the RCVS Council election. Veterinary surgeons may each vote for up to six candidates to fill these seats, which fall vacant as elected Council member's terms of office expire at the RCVS Annual General Meeting (6 July). In 2012, five existing Council members are seeking re-election, and nine new candidates are standing.
Of the 42 RCVS Council members, four are appointed by the Privy Council, 14 by the veterinary schools and 24 by direct election; each member serves a four year term. This year's candidates are:
Voting opens from Friday 9 March and all veterinary surgeons eligible to vote should receive their ballot papers shortly. Votes must be received by 5pm on 27 April 2012 and, as in previous years, can be cast online, by post, or by text message
Virbac Animal Health has launched a broad spectrum wormer for dogs called Endogard (praziquantel, pyrantel and febantel).
Virbac says Endogard offers treatment against most types of intestinal worms found commonly in dogs. It is presented in two tablet sizes for easy dosage.
Victoria Hudson, Product Manager for Endo and Ectoparasiticides, said: "While we're known for developing innovative products which help practices generate additional revenue streams, we can also support them by offering cost-effective and proven products for routine use.
Endogard is a perfect example. The efficacy of its active ingredients is well-established; it's simple for owners to administer and it's also affordable which will bring them back to the practice. It's an excellent addition to Virbac's strong range of parasite control treatments."
For further information, contact your Territory Manager or call Virbac on 01359 243243.
Burgess Excel has extended its range with what it claims is the UK's most absorbent paper bedding for rabbits, guinea pigs and chinchillas, and a new 'sensitive' variety of nuggets for rabbits and guinea pigs.
Burgess says the bedding is made from environmentally-friendly high quality virgin wood pulp which locks away moisture and liquids quickly and securely. The company also highlights the fact that it is made using advanced, specialised drying and dust extraction techniques to prevent respiratory problems and eye infections which can occur when there is a large amount of dust present in a fibrevore's environment.
The new rabbit and guinea pig nuggets contain 46% Beneficial Fibre with a grain free recipe for delicate digestive systems.
To find out more about the new products, visit www.excelfeedingplan.com/ or contact 0800 413 969.
Colonel Neil Smith has been elected Vice-President of the Royal College of Veterinary Surgeons. He takes up office at RCVS Day on 6 July 2012.
Neil graduated from the Royal Veterinary College in 1989, and was commissioned into the Royal Army Veterinary Corps (RAVC) with the intention of staying for four years. Twenty-two years later, he is now the Director Army Veterinary and Remount Services, effectively the Chief Veterinary Officer for the Army and head of the RAVC, which currently has over 35 Veterinary Officers.
He has held a mixture of clinical, staff and command positions, and has worked in the UK, US and Germany. He has Masters' Degrees in Food Science, Defence Administration and Defence Studies. He has also worked part-time in small animal practice (including the Blue Cross, of which he is now a Trustee), and was heavily involved in the Foot and Mouth Disease outbreak in 2001.
First elected to Council in 2004, Neil was re-elected in 2010 after a short break. He has served on Education, Advisory, Preliminary Investigation and Planning and Resources Committees, and on VN Council (currently Vice-Chairman and Chairman of the Awarding Body).
He has also previously been President of the RVC Student Union Society, the RVC Alumnus Association, Southern Counties, and the Association of Government Veterinarians. He is currently a Council member of the Central Veterinary Society, and has previously sat on the BVA's Veterinary Policy Group.
Neil said: "I am honoured to have been elected as the next Vice-President. The College is about to go through some significant organisational changes, not least because of the proposed legislative reform order. However, I aim to ensure that we remain focused on our primary role in safeguarding the health and welfare of animals committed to veterinary care. The functions of the RCVS are quite diverse, and I am keen that we try to enhance both the profession's and the public's understanding of our remit, including our responsibility for educational, ethical and clinical standards."
Jacqui Molyneux has been confirmed as President, and Dr Jerry Davies as Vice-President, effective July 2012.
Eurovet Animal Health has launched Thyforon Flavoured (levothyroxine sodium, POM-V), which replaces the company's canine hypothyroid treatment Forthyron.
Eurovet says that Thyforon Flavoured has the same clinical efficacy of Forthyron and veterinary surgeons won't need to make any dose adjustments when transitioning to the new product.
However, Thyforon Flavoured, with its palatable formulation, now offers the benefit of being voluntarily accepted by over 70 per cent of dogs in taste trials1. In addition there is a new 800 mcg formulation which gives more prescribing options, particularly for the treatment of large and giant breeds.Thyforon Flavoured comes as easy-break tablets to make dose adjustment straightforward, in an easy-to-dispense blister pack.
Thyforon Flavoured is available now - the person responsible for placing the practice drug order should just ask for Thyforon Flavoured when placing the next drug order and where appropriate, the practice management system should be updated to reflect the new name.
Reference1. Eurovet Animal Health Internal Study report, acceptance study, November 2011
Animalcare has launched Emdocam (meloxicam 20mg/ml), a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class for use in cattle, pigs and horses.
According to the company, Emdocam disrupts the inflammatory cascade by inhibiting prostaglandin synthesis. It is a potent and preferential inhibitor of COX-2, permitting sufficient COX-1 sparing activity. It has analgesic and anti-inflammatory effects. When administered in a single dose to cattle, it has long acting anti-endotoxic, anti-pyretic and anti-inflammatory effects for up to three days.1,2
In cattle, it is indicated for bovine respiratory disease (BRD), clinical mastitis and calf scour. Animalcare says early use of meloxicam for BRD reduces pyrexia and pain, especially in young calves and improves feed intake. Meloxicam plus an antibiotic significantly reduced the extent of lung lesions, leading to improved clinical efficacy and daily liveweight gain in comparison with animals treated with antibiotics alone, for example oxytetracycline,3 florfenicol4and tilmicosin. 5
In the case of clinical mastitis, Animalcare says that used adjunctively with an antibiotic, Emdocam helps relieve local and systemic inflammation, returns the udder to a normal condition and reduces the polymorphonuclear leucocytes (PMN) response. In a large scale, double-blinded study in New Zealand, the addition of meloxicam to antibiotic therapy resulted in lower Somatic Cell Counts and a reduced risk of culling in dairy cows with mild clinical mastitis.6
Calf scour treated with meloxicam, as a supportive therapy, can improve calf well-being and reduce morbidity. In a double-blinded, controlled study, the use of meloxicam improved daily water and feed intake, added greater average bodyweight (bw) gain and helped calves to wean earlier. 7
In horses, administered IV at 3.0ml/100kg bw, Emdocam can be used for musculo-skeletal disorders, as well as colic, resulting in reduced pain and inflammation. In a study of 18 horses comparing flunixin with meloxicam and designed to determine the effect on recovery of ischemic-injured jejunum, meloxicam was found to be a useful alternative for the post-operative treatment of colic. 8
Emdocam is also indicated in pigs for non-infectious locomotive disorders and as an adjunctive therapy with an antibiotic in puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome).
Tony Liepman from Animalcare said: "Emdocam is competitively priced whether used on its own or adjunctively with a long-acting intramuscular (IM) antibiotic, such as Florgane suspension for the treatment of BRD in calves. This, coupled with its long lasting, low volume (2.5ml/100kg bw in cattle), single dose administration, by intravenous (IV) or subcutaneous (SC) injection, makes Emdocam a highly efficacious and practical NSAID."
Emdocam is a POM-V medicine and available as 50 and 100ml multi-dose vials. Withdrawal period in cattle for meat and offal is 15 days and in pigs for meat and offal is 5 days. In horses for meat and offal it is 5 days. In Florgane [POM-V], the withdrawal period for meat and offal is 37 days in cattle and not to be used in cattle producing milk for human consumption
References
Cattle
Research carried out by the Kennel Club to coincide with Mother's Day has revealed that 35% of dog buyers do not see their new puppy with its mother.
The research also found that one in ten buyers take their puppy home before it is eight weeks old, and that 55% do not see the puppy in its breeding environment.
Bill Lambert, Manager of the Kennel Club Assured Breeder Scheme, said: "March is the most popular month for searching for a puppy, but we are extremely concerned that so many are not seeing their puppy with its mother. Seeing mum not only helps people to find out how their puppy will be likely to turn out in terms of temperament and characteristics, but it also gives them the reassurance that it has been bred in a loving environment where it has been cared for and socialised properly."
Marc Abraham, TV vet and Kennel Club Veterinary Advisor, said: "Puppies depend on their mums in the early weeks of life, not just for milk but she's also critical for developing their socialisation skills which help set them up for life. If a breeder refuses to show the puppy with its mother without very good reason, then buyers should go elsewhere."
The Kennel Club is urging people to see puppies with their mother as part of its Stop Puppy Farming campaign and is joining with Marc Abraham to support the 'Where's Mum?' campaign. Kennel Club research has shown that as many as one in four could unwittingly be buying their puppy from a puppy farm.
The Kennel Club will be running a National Puppy Awareness Week (PAW) from the 8th - 14th September. To find out more visit www.thekennelclub.org.uk/stoppuppyfarming.
Virbac Animal Health has launched a special scheme to encourage farmers to have milk samples analysed in line with the industry-wide campaign to promote the responsible use of antimicrobials.
Under the terms of the scheme, veterinary surgeons purchasing Virbac's Cephaguard DC therapy will receive vouchers to distribute to their farmer clients. These vouchers can be redeemed for milk bacteriology to determine the pathogens causing mastitis and so ensure treatment is more targeted and effective.
Brigitte Goasduf MRCVS, Ruminants Marketing Manager at Virbac, said: "Mastitis is a major concern for dairy farmers with reported numbers of cases ranging from 26-50 for every 100 cows.
"Experts agree that individual SCC monitoring and the accurate diagnosis of pathogens causing infection are key to treating mastitis effectively. Unfortunately many farmers are often deterred by the cost.
"Our scheme gives our veterinary customers the opportunity to foster good practice by encouraging farmer clients to submit milk samples for investigation at no cost to them. This will then enable them to treat the bacteria causing the infection in line with industry guidelines for the use of antimicrobials.
"Over time, we believe farmers will come to realise that adopting this more targeted approach is not only more cost-effective but will also preserve their ability to treat their herd, both now and in the future."
For further information on the scheme, contact your Virbac territory manager or call Virbac on 01359 243243.
Henry Schein Inc., parent company of Henry Schein Animal Health has been named as one of Ethisphere's 2012 World's Most Ethical Companies.
The Ethisphere Institute is an international think-tank dedicated to the creation, advancement and sharing of best practices in business ethics, corporate social responsibility, anti-corruption and sustainability. This is the sixth year that Ethisphere Institute has published the World's Most Ethical Companies list.
Out of more than 5,000 nominations for the World's Most Ethical Companies award this year, Henry Schein was named to the list of 145 companies for raising the bar for ethical standards within the health care industry through exemplary ethical leadership, worldwide business standards and commitment to corporate social responsibility.
Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc. said: A deep commitment to the highest ethical standards and business practices has been a hallmark of Henry Schein since our founding in 1932, and continues to be at the very core of our business model as we have grown to become a Fortune 500 company with operations around the globe and nearly 15,000 Team Schein Members."
Virbac Animal Health has launched an enhanced version of its flea and tick spot-on Effipro (fipronil) to help pet owners master the art of 'spotonologyTM - a Maureen-Lipmanesque term the company has coined to describe the optimum application of a spot on treatment.
Effipro is now presented in a clear pipette featuring 'Drop-lock' technology to provide precise finger tip control of the flow of liquid with no risk of drip or leakage. The pipette has also been redesigned to ensure it is simple to open and that users can easily check that all the treatment has been dispensed.
Virbac says Effipro is priced to offer an effective but affordable solution to parasite control. It is presented in client packs of four pipettes and in practice packs of 24 to offer flexible dispensing opportunities. It is also available in a spray form.
Victoria Hudson, Product Manager at Virbac, said: "Parasite control is a key revenue generator for many practices. It also presents a great opportunity to create loyal, bonded clients as fleas and ticks cause great concern to pet owners.
"Effipro is already a popular product but we know that some owners find using spot-ons difficult and worry about the risk of the liquid getting on to their fingers or on furniture, particularly if their pets move around while the treatment is being applied.
"With this in mind, we've taken a fresh look at the technology of spot-ons in order to ensure that we're providing a solution which is as simple and hassle-free as possible. As a first step, we've redesigned our pipette. Our unique Drop-lock technology means that owners can start or stop the flow of liquid with their finger tips, giving them full control over where and when the product is applied. The new see-through design and enhanced opening mechanism also make the new version of Effipro more convenient to use.
"We've had great feedback from practices which have trialled the product and believe it represents a significant step forward for users of spot-ons. We are, of course, providing a range of support materials and product promotions to support its launch and look forward to working with our customers to ensure that their clients become expert and enthusiastic 'Spot.on.ologists' during 2012.
For further information about Effipro contact your Territory Manager or call Virbac on 01359 243243.
BVA members who join the Webinar Vet before the end of this month will receive a USB headset and microphone worth £40
Webinar Vet founder Anthony Chadwick MRCVS said: "The idea is to help new members get equipped and ready to listen and ask questions during the regular Thursday evening member webinars."
"BVA members already benefit from half price gold membership to the Webinar Vet and many have already taken advantage and are enjoying the many benefits of online CPD."
Gold membership includes invitations to weekly members' live CPD events, full access to the library of over 150 hours of categorised pre-recorded webinars, and a monthly CD of one of the presentations to listen to in the car.
All BVA members who sign up before March 31st will also qualify for the free headset. For more information visit www.bva.co.uk/webinar.